Cogent Biosciences, Inc. COGT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$354.3M-7.7% | -$328.94M-11.7% | -$294.37M-3.6% | -$284.08M-5.4% | -$269.5M-5.3% | ||
| $2.55M-0.5% | $2.56M+0.1% | $2.56M+0.8% | $2.54M+2.0% | $2.49M+1.7% | ||
| $52.98M+15.0% | $46.08M+14.3% | $40.31M+0.6% | $40.06M-0.7% | $40.36M+1.5% | ||
| -$284.82M-7.7% | -$264.44M-7.5% | -$245.92M-5.3% | -$233.61M-5.3% | -$221.77M-6.7% | ||
| $1.46M-6.3% | $1.55M+90.0% | $818K-20.8% | $1.03M-1.6% | $1.05M+83.2% | ||
| -$505.36M-26.5% | -$399.53M-2,548% | -$15.09M-108% | $200.15M+87.7% | $106.61M+179% | ||
| —— | $54.64M+33.3% | $40.98M+50.0% | $27.32M+100% | $13.66M— | ||
| $905.8M+3.1% | $878.23M+203% | $289.59M+298% | $72.85M+184% | $25.62M-88.1% | ||
| $117.59M-45.6% | $216.23M+608% | $30.55M-22.4% | $39.38M— | —— | ||
| -$286.27M-7.6% | -$266M-7.8% | -$246.73M-5.2% | -$234.65M-5.3% | -$222.82M-6.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cogent Biosciences, Inc. generate?
- Cogent Biosciences, Inc. (COGT) generated -$284.8M in operating cash flow over the trailing twelve months.
- What is Cogent Biosciences, Inc.'s free cash flow?
- After $1.5M of capital expenditures, Cogent Biosciences, Inc.'s free cash flow was -$286.3M over the trailing twelve months, down 28.5% year over year.
- Where does Cogent Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Cogent Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
